Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency causes age-dependent progression of female osteoporosis.
Bone strength
Estrogen
Fracture resilience
Nrf2
Osteoporosis
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
25 Nov 2022
25 Nov 2022
Historique:
received:
20
08
2022
accepted:
02
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial transcription factor for cellular redox homeostasis. The association of Nrf2 with elderly female osteoporotic has yet to be fully described. The aim was to elucidate a potential age-dependent Nrf2 contribution to female osteoporosis in mice. Eighteen female wild type (WT) and 16 Nrf2-knockout (KO) mice were sacrificed at different ages (12 weeks = young mature adult and 90 weeks = old) to analyze their femurs. The morphological properties (trabecular and cortical) were evaluated by micro-computed tomography (μCT) and compared to gold standard histochemistry analysis. The quasi-static compression tests were performed to calculate the mechanical properties of bones. Additionally, the population of bone resorbing cells and aromatase expression by osteocytes was immunohistochemically evaluated and empty osteocyte lacunae was counted in cortical bone. Old Nrf2-KO mice revealed a significantly reduced trabecular bone mineral density (BMD), cortical thickness, cortical area, and bone fraction compared to old WT mice, regardless of no significant difference in skeletally mature young adult mice between WT and KO. Specifically, while all old WT mice showed thin metaphyseal trabeculae, trabecular bone was completely absent in 60% of old KO mice. Additionally, old KO mice showed significantly more osteoclast-like cells and fewer aromatase-positive osteocytes than WT mice, whereas the occurrence of empty osteocyte lacunae did not differ between both groups. Nrf2-KO mice further showed an age-dependently reduced fracture resilience compared to age-matched WT mice. Our results suggest that chronic Nrf2 loss can lead to age-dependent progression of female osteoporosis.
Sections du résumé
BACKGROUND
BACKGROUND
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial transcription factor for cellular redox homeostasis. The association of Nrf2 with elderly female osteoporotic has yet to be fully described. The aim was to elucidate a potential age-dependent Nrf2 contribution to female osteoporosis in mice.
METHODS
METHODS
Eighteen female wild type (WT) and 16 Nrf2-knockout (KO) mice were sacrificed at different ages (12 weeks = young mature adult and 90 weeks = old) to analyze their femurs. The morphological properties (trabecular and cortical) were evaluated by micro-computed tomography (μCT) and compared to gold standard histochemistry analysis. The quasi-static compression tests were performed to calculate the mechanical properties of bones. Additionally, the population of bone resorbing cells and aromatase expression by osteocytes was immunohistochemically evaluated and empty osteocyte lacunae was counted in cortical bone.
RESULTS
RESULTS
Old Nrf2-KO mice revealed a significantly reduced trabecular bone mineral density (BMD), cortical thickness, cortical area, and bone fraction compared to old WT mice, regardless of no significant difference in skeletally mature young adult mice between WT and KO. Specifically, while all old WT mice showed thin metaphyseal trabeculae, trabecular bone was completely absent in 60% of old KO mice. Additionally, old KO mice showed significantly more osteoclast-like cells and fewer aromatase-positive osteocytes than WT mice, whereas the occurrence of empty osteocyte lacunae did not differ between both groups. Nrf2-KO mice further showed an age-dependently reduced fracture resilience compared to age-matched WT mice.
CONCLUSION
CONCLUSIONS
Our results suggest that chronic Nrf2 loss can lead to age-dependent progression of female osteoporosis.
Identifiants
pubmed: 36434613
doi: 10.1186/s12891-022-05942-1
pii: 10.1186/s12891-022-05942-1
pmc: PMC9700883
doi:
Substances chimiques
NF-E2-Related Factor 2
0
Aromatase
EC 1.14.14.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1015Informations de copyright
© 2022. The Author(s).
Références
Biochem Biophys Res Commun. 2022 May 14;604:109-115
pubmed: 35303676
IUBMB Life. 2007 Jan;59(1):27-33
pubmed: 17365177
J Bone Miner Res. 2013 Mar;28(3):627-38
pubmed: 23109114
Australas Phys Eng Sci Med. 2008 Jun;31(2):160-4
pubmed: 18697709
Bone. 2021 Apr;145:115040
pubmed: 31437568
Bone. 2015 May;74:1-9
pubmed: 25576674
Neuroscience. 2000;95(1):293-307
pubmed: 10619486
J Bone Miner Res. 2011 Feb;26(2):229-38
pubmed: 21254230
Sci Rep. 2020 Jan 15;10(1):348
pubmed: 31941926
Exp Cell Res. 2014 Nov 1;328(2):351-60
pubmed: 25172557
J Osteoporos. 2011;2011:230671
pubmed: 21772971
Theranostics. 2016 Jan 01;6(3):328-41
pubmed: 26909109
J Orthop Res. 1991 Sep;9(5):674-82
pubmed: 1870031
Int J Mol Sci. 2022 Jan 25;23(3):
pubmed: 35163300
Calcif Tissue Int. 2014 Oct;95(4):349-61
pubmed: 25096517
Clin Sci (Lond). 2015 Dec;129(12):989-99
pubmed: 26386022
Antioxidants (Basel). 2020 Sep 10;9(9):
pubmed: 32927924
Free Radic Biol Med. 2019 Feb 20;132:67-72
pubmed: 30189265
Commun Biol. 2021 May 14;4(1):576
pubmed: 33990683
Bonekey Rep. 2014 Aug 20;3:564
pubmed: 25184037
Biochim Biophys Acta Mol Cell Res. 2018 May;1865(5):721-733
pubmed: 29499228
J Bone Miner Res. 1997 Sep;12(9):1416-23
pubmed: 9286757
Toxicol Sci. 2019 Jun 1;169(2):485-498
pubmed: 30825315
Calcif Tissue Int. 2005 Nov;77(5):281-90
pubmed: 16283571
Int J Hypertens. 2012;2012:890671
pubmed: 22518296
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
PLoS One. 2017 Feb 2;12(2):e0171161
pubmed: 28152064
Bone. 2007 Oct;41(4):505-15
pubmed: 17693147
J Biol Chem. 2013 Aug 9;288(32):23009-20
pubmed: 23801334
Calcif Tissue Int. 2019 Oct;105(4):341-352
pubmed: 31236620
Am J Pathol. 2019 Jun;189(6):1145-1158
pubmed: 30926333
J Biochem Mol Toxicol. 2012 Jul;26(7):264-9
pubmed: 22730333
Bone. 2009 Jan;44(1):71-9
pubmed: 18973838
Neuroendocrinology. 2013;97(3):232-41
pubmed: 22948038
Bone Res. 2021 Feb 26;9(1):15
pubmed: 33637693
J Orthop Res. 2018 Nov;36(11):2987-2995
pubmed: 29877577
Endocr Connect. 2020 Apr;9(4):R70-R80
pubmed: 32168472
Antioxidants (Basel). 2022 Feb 06;11(2):
pubmed: 35204201
Bone Res. 2014 Nov 11;2:14033
pubmed: 26273528
Arthritis Rheum. 2011 Aug;63(8):2385-95
pubmed: 21484764
Oxid Med Cell Longev. 2014;2014:726590
pubmed: 25120886
J Bone Joint Surg Am. 2021 Aug 4;103(15):1451-1461
pubmed: 34014853
J Clin Endocrinol Metab. 2003 Apr;88(4):1523-7
pubmed: 12679433